Overview
Pendar Technologies develops handheld Raman devices, such as the Pendar X10 and Robot Integration Kit, for real-time, on-site chemical analysis and remote identification. The systems use wavelength-tunable Quantum Cascade Laser arrays to excite samples and capture Raman signals, enabling fast chemical detection with possible standoff and robotic integration. They work with researchers, clinicians, and government customers (including the U.S. Army and DHS) and earn revenue from direct device and kit sales as well as grants and pilot programs. The aim is to be a leading provider of practical, portable chemical analysis tools that deliver fast, actionable results in field, clinical, and national-security environments.
Work here?Claim your company
Simplify's Take
What believers are saying
- DHS awarded Pendar $999,130 on April 1, 2025 for synthetic-opioid detection.
- NASA funded two 2025 awards, including a September 29, 2025 QCL contract.
- Pendar exhibited at HAZMAT 2026 on September 3, 2026, signaling active field demand.
What critics are saying
- Pendar still depends on federal SBIR contracts, not recurring commercial revenue.
- Both 2025 awards end in 2026-2027, creating a cliff if follow-on funding misses.
- Without major agency adoption, Pendar becomes a grant-funded lab, not a durable business.
What makes Pendar Technologies unique
- X10 standoff Raman identifies hazards from six feet without sample contact.
- Pendar pairs quantum-cascade-laser arrays with Raman and photonic-integrated spectroscopy R&D.
- Its 2026 HAZMAT focus spans responders, EOD, military, and law-enforcement users.
Help us improve and share your feedback! Did you find this helpful?